Personal genome analysis available online

Prof Ana Santos Rutschman talks about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.

Dr Steven Goodman talks about the ethical and scientific implications of breaking the blind of placebo-controlled COVID-19 vaccine trials.

Dr Arthur Caplan talks about ethical issues surrounding the development, production, and use of potential SARS-CoV-2 vaccine.

Dr Caleb Alexander examines the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Drs Stefano Bertozzi and Jeffrey Mackie-Mason talk about business models of scientific publishing that advance biomedical knowledge and discovery.

There is a market for direct-to-consumer genetic testing and a need for better consumer information and more regulation of tests and testing laboratories.

Research questions must be answered to inform policy decisions about the hereditary diseases and conditions for which newborns should be tested.

The question of whether and how results from personal genetic testing will motivate behavioral changes in consumers has only begun to receive the research attention it richly deserves.

Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision.